Sentinel Node in Oral Cancer: The Nuclear Medicine Aspects. A Survey from the Sentinel European Node Trial.

MLA

Tartaglione, Girolamo, et al. “Sentinel Node in Oral Cancer: The Nuclear Medicine Aspects. A Survey from the Sentinel European Node Trial.” Clinical Nuclear Medicine, vol. 41, no. 7, July 2016, pp. 534–42. EBSCOhost, https://doi.org/10.1097/RLU.0000000000001241.

APA

Tartaglione, G., Stoeckli, S. J., de Bree, R., Schilling, C., Flach, G. B., Bakholdt, V., Sorensen, J. A., Bilde, A., von Buchwald, C., Lawson, G., Dequanter, D., Villarreal, P. M., Forcelledo, M. F. F., Amezaga, J. A., Moreira, A., Poli, T., Grandi, C., Vigili, M. G., O’Doherty, M., … McGurk, M. (2016). Sentinel Node in Oral Cancer: The Nuclear Medicine Aspects. A Survey from the Sentinel European Node Trial. Clinical Nuclear Medicine, 41(7), 534–542. https://doi.org/10.1097/RLU.0000000000001241

Chicago

Tartaglione, Girolamo, Sandro J Stoeckli, Remco de Bree, Clare Schilling, Geke B Flach, Vivi Bakholdt, Jens Ahm Sorensen, et al. 2016. “Sentinel Node in Oral Cancer: The Nuclear Medicine Aspects. A Survey from the Sentinel European Node Trial.” Clinical Nuclear Medicine 41 (7): 534–42. doi:10.1097/RLU.0000000000001241.